Psychiatry & Neurology, Clinical Neurophysiology · Houston, TX
NPI
1871858258
Since 2012
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
6410 Fannin St Ste 1014
Houston, TX, 77030
Phone (832) 325-7080
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
325 services
Medicare patients, 2024
151
Average age 72
Drug cost, 2024
$2.4M
1,215 prescriptions
Company payments, 2025
$1,002
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristin Brown was code 95885 (electrical nerve conductivity), 57 times for 39 patients. In total Kristin Brown billed 325 services in 17 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95885 Electrical Nerve Conductivity | Office | 57 | 39 | $48.19 | $2,747 |
| 99214 Office E&M - Established | Office | 48 | 42 | $80.61 | $3,870 |
| 95886 Electrical Nerve Conductivity | Office | 45 | 37 | $74.70 | $3,361 |
| 99215 Office E&M - Established | Office | 44 | 39 | $131.23 | $5,774 |
| 99205 Office E&M - New | Office | 26 | 26 | $167.22 | $4,348 |
| 95910 Electrical Nerve Conductivity | Office | 24 | 24 | $129.81 | $3,115 |
| 95909 Electrical Nerve Conductivity | Office | 17 | 17 | $100.23 | $1,704 |
| 99204 Office E&M - New | Office | 14 | 14 | $89.16 | $1,248 |
| 95911 Electrical Nerve Conductivity | Office | 13 | 13 | $153.94 | $2,001 |
By year: 2022 $28K for 252 services; 2023 $30K for 303 services; 2024 $32K for 325 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristin Brown prescribed most often to Medicare patients was Gabapentin, with 82 prescriptions and refills. In total Kristin Brown wrote 1,215 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 82 | 179 | 28 | $2,383 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 62 | 62 | 12 | $472 |
| Duloxetine Hcl Generic | 53 | 98 | 15 | $1,135 |
| Pregabalin Generic | 48 | 84 | 19 | $2,154 |
| Sodium Chloride 0.9 % Sodium Chloride | 45 | 50 | Under 11 | $254 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 45 | 45 | Under 11 | $412K |
| Emgality Pen Galcanezumab-Gnlm | 44 | 50 | Under 11 | $35K |
| Levetiracetam Generic | 39 | 77 | 12 | $1,726 |
| Nurtec Odt Rimegepant Sulfate | 36 | 36 | Under 11 | $50K |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 34 | 34 | Under 11 | $336K |
| Botox Onabotulinumtoxina | 34 | 95 | 12 | $44K |
| Pyridostigmine Bromide Generic | 33 | 62 | Under 11 | $2,289 |
| Topiramate Generic | 31 | 65 | Under 11 | $249 |
| Donepezil Hcl Generic | 31 | 73 | Under 11 | $104 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 30 | 30 | Under 11 | $219K |
Brand drugs: 438 claims; generic drugs: 777 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristin Brown $1,002 ($1,002 in general payments such as food, travel and fees) from 17 companies. The largest payer was Pfizer Inc. with $255.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 12 | $255 |
| UCB, Inc. UCB.BR | 4 | $155 |
| Abbvie Inc. ABBV | 5 | $128 |
| Argenx US, Inc. ARGX | 5 | $115 |
| CSL Behring CSL.AX | 3 | $75.82 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $37.02 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $32.41 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $28.12 |
| Baxter Healthcare BAX | 1 | $26.33 |
| Hospira, Inc. PFE | 1 | $23.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.